Daniel Ontaneda, MD, PhD
Daniel Ontaneda, MD, PhD, is an associate professor of Neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and a staff member at the Cleveland Clinic Neurological Institute’s Mellen Center for Multiple Sclerosis.
Dr. Ontaneda is the lead principal investigator for a large international multicenter study examining early highly effective versus escalation approaches in multiple sclerosis (DELIVER-MS).He is also the Principal investigator for the Central vein Study in MS , a multi-center trial funded by the NIH/NINDS (U01) examining the role of central vein in the diagnosis of MS. He is also a member of the Executive Steering Committee for the North American Imaging in Multiple Sclerosis Cooperative. . Dr. Ontaneda is a member of the Multiple Sclerosis Functional Composite Task Force. Dr. Ontaneda’s research is funded by the National Institutes of Health, National Multiple Sclerosis Society, Race to Erase Foundation, and Patient Centered Outcomes Research Institute. Dr. Ontaneda was the recipient of a Sylvia Lawry NMSS clinical Fellowship Award, NIH KL2 Cleveland CTSA career transition award. Dr. Ontaneda received his doctor of medicine from the Pontificia Universidad Católica del Ecuador and Ph.D. in Statistics and Epidemiology at Case Western Reserve University, and Master of Science from Case Western Reserve University. He completed a postdoctoral research fellowship at Baylor College of Medicine, Houston, Texas. He then completed his neurology residency and a neuroimmunology fellowship at the Cleveland Clinic Foundation.